The global medical industry experienced a 32% decline in the number of cybersecurity-related patent applications in Q3 2023 compared with the previous quarter. The total number of cybersecurity-related grants dropped by 26% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Medical Devices: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of cybersecurity-related patent applications in the medical industry was 469 in Q3 2023, versus 693 in the prior quarter.
The top five companies accounted for 11% of patenting activity
Analysis of patenting activity by companies shows that johnson & johnson filed the most cybersecurity patents within the medical industry in Q3 2023. The company filed 14 cybersecurity-related patents in the quarter, compared with 24 in the previous quarter. It was followed by DexCom with 13 cybersecurity patent filings, Samsung Group (11 filings), and I-Sens (7 filings) in Q3 2023.
Patenting activity was driven by the US with a 47% share of total patent filings
The largest share of cybersecurity related patent filings in the medical industry in Q3 2023 was in the US with 47%, followed by China (16%) and South Korea (9%). The share represented by the US was 8% higher than the 39% share it accounted for in Q2 2023.
For further understanding of GlobalData's Medical Devices: Patents Trends Q3 2023, buy the databook here.